Navigating Oral Therapy in Breast Cancer: Practice Strategies to Promote Medication Adherence

The Academy of Oncology Nurse & Patient Navigators (AONN+) and Eli Lilly and Company Medical Affairs are pleased to present a live webinar designed to facilitate conversations with patients regarding adherence to breast cancer treatments. Attendees will have an opportunity to participate in a live Q&A following the presentation.

Attendees will be able to:

  • Describe the role of the nurse navigator within the multidisciplinary team in supporting medication adherence & persistence
  • Identify modifiable factors associated with medication non-adherence amenable to nursing intervention
  • Apply evidence-based psychological approaches to support medication adherence in clinical practice
  • Construct strategies to improve adherence & persistence in practice using a breast cancer case study


Robert J. Ferguson, PhD
Clinical Psychologist and Assistant Professor of Medicine
Division of Hematology/Oncology
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center
Pittsburgh, PA

Madelaine C. Kuiper, NP
Hematology Oncology
UCLA Health System
Santa Monica, CA

Maryam Lustberg, MD, MPH
Associate Professor of Internal Medicine (Medical Oncology)
Director, Center for Breast Cancer
Chief, Breast Medical Oncology
Yale Cancer Center
New Haven, CT

VV-MED-128153 09/2022 CPS REG1058951
© 2022 Lilly USA, LLC. All rights reserved.

Related Articles
Improving Adherence to Oral Oncolytics in Breast Cancer: The Pivotal Role of Nurse Navigators
September 2022 Vol 13, No 9
Oral oncolytic drugs have a multitude of benefits for patients, including ease of use, improved quality of life, fewer clinic visits, and no need for IV therapy.
Breast Cancer Screening Among Women with Comorbidities: A Cross-Sectional Examination of Disparities from the Behavioral Risk Factor Surveillance System
Ashton Gatewood, MPH, BSN, RN, Mackenzie Enmeier, BS, Elise Stephenson, BA, Jordyn Austin, BS, Benjamin Greiner, DO, MPH, Micah Hartwell, PhD
June 2022 Vol 13, No 6
Do comorbid diagnoses affect breast cancer screening rates? The authors of this study present their findings.
What AYAs with Breast Cancer and Their Providers Tell Us About Survivorship Needs
Heather Becker, PhD, Molly McAdam, MPH, Sharyn Malatok, MPA, Emily Croce, MSN, APRN, CPNP-PC, Eunju Choi, PhD, Elaine Gonzales, CN-BA, CHW, CHWI
April 2022 Vol 13, No 4
Last modified: November 15, 2022

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State